Search Results 171-180 of 17063 for EBV

  1. Teplizumab-mzwv (intravenous route) - Side effects & uses - Mayo Clinic

    Virus infection (eg, Epstein-Barr virus, cytomegalovirus)—Use is not recommended in patients with these conditions. Liver disease—Use with caution. May make ...

  2. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  3. Headache - Mayo Clinic

    Mononucleosis and Epstein-Barr: What's the connection? Mononucleosis: Can it recur? Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) ...

  4. Cancer Clinical Trials - Mayo Clinic Research

    ... EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder Rochester, MN ... Epstein-Barr virus-positive, cluster of differentiation (CD)20 ...

  5. https://www.mayoclinic.org/chinese_organization_concepts.xml

  6. Publications - David Li, M.D. - Mayo Clinic

    PD-L1 protein expression in most EBV-driven lymphoproliferative disorders is not associated with 9p24.1 amplification Hematopathology. 2017 Mar; 2(2):58-68 ...

  7. Biobank for Cholestatic Liver Diseases - Clinical Trials

    About this study. This study is a biobank of specimens and clinical data for use in current and future research to better understand the cholestatic liver ...

  8. Phase 2 Study with TTI-622 and TTI-621 in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) - Mayo Clinic

    EBV positive DLBCL, NOS. DLBCL associated with chronic inflammation. Intravascular large B-cell lymphoma. ALK positive large B-cell lymphoma. Relapsed ...

  9. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  10. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

    About this study. This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior ...